GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » EPS (Diluted)

Onward Medical NV (XBRU:ONWD) EPS (Diluted) : €-1.20 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV EPS (Diluted)?

Onward Medical NV's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was €-0.56. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.20.

Onward Medical NV's EPS (Basic) for the six months ended in Dec. 2023 was €-0.56. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.20.

Onward Medical NV's EPS without NRI for the six months ended in Dec. 2023 was €-0.56. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Onward Medical NV EPS (Diluted) Historical Data

The historical data trend for Onward Medical NV's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV EPS (Diluted) Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -2.29 -3.39 -3.62 -1.09 -1.20

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.71 -0.53 -0.56 -0.64 -0.56

Competitive Comparison of Onward Medical NV's EPS (Diluted)

For the Biotechnology subindustry, Onward Medical NV's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onward Medical NV's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's PE Ratio distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's PE Ratio falls into.



Onward Medical NV EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Onward Medical NV's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-36.181-0)/30.184
=-1.20

Onward Medical NV's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-16.899-0)/30.184
=-0.56

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV  (XBRU:ONWD) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Onward Medical NV EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Onward Medical NV (XBRU:ONWD) Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (XBRU:ONWD) Headlines

No Headlines